Evidence Gaps Analysis
3688 outcomes from 214 review series
CD007154
Current Version: CD007154.PUB2
Current Evidence Gaps 4 gaps
| Population | Intervention | Comparison | Outcome | Evidence Level | Downgrade Reason |
|---|---|---|---|---|---|
| Children aged 10-16 years | Hypnosis with oxygen | Inhalation sedation with nitrous oxide | Behavioral response during extraction | No Evidence Yet | N/A |
| Children aged 4-13 years | Hypnosis | No hypnosis | Crying during LA administration | No Evidence Yet | N/A |
| Children aged 4-13 years | No hypnosis | No hypnosis | Crying during LA administration | No Evidence Yet | N/A |
| Children mean age 10.78 years | Hypnosis | Verbal motivation | Orthodontic headgear wear compliance | No Evidence Yet | N/A |
CD007156
Current Version: CD007156.PUB3
| 1 older version
Current Evidence Gaps 35 gaps
| Population | Intervention | Comparison | Outcome | Evidence Level | Downgrade Reason |
|---|---|---|---|---|---|
| People with oral submucous fibrosis | Antioxidant | Placebo | Interincisal distance (> 6 months) | Low | Not specified |
| People with oral submucous fibrosis | Antioxidant | Placebo | Interincisal distance (< 3 months) | Low | Not specified |
| People with oral submucous fibrosis | Pentoxifylline | Placebo | Interincisal distance (< 3 months) | Low | Not specified |
| People with oral submucous fibrosis | Antioxidant | Placebo | Burning sensation (< 3 months) | Moderate | Not specified |
| People with oral submucous fibrosis | Antioxidant | Placebo | Interincisal distance (3-6 months) | Moderate | Not specified |
| People with oral submucous fibrosis | Antioxidant | Placebo | Burning sensation (3-6 months) | Moderate | Not specified |
| People with oral submucous fibrosis | Antioxidant | Placebo | Burning sensation (> 6 months) | Moderate | Not specified |
| People with oral submucous fibrosis | Antioxidant | Placebo | Participant?reported resumption of normal eating, chewing and speech | No Evidence Yet | N/A |
| People with oral submucous fibrosis | Antioxidant | Placebo | Adverse effects | No Evidence Yet | N/A |
| People with oral submucous fibrosis | Dexamethasone | Placebo | Adverse effects | No Evidence Yet | N/A |
| People with oral submucous fibrosis | Dexamethasone | Placebo | Interincisal distance (> 6 months) | No Evidence Yet | N/A |
| People with oral submucous fibrosis | Dexamethasone | Placebo | Burning sensation (> 6 months) | No Evidence Yet | N/A |
| People with oral submucous fibrosis | Hydrocortisone + hyaluronidase | Placebo | Interincisal distance (> 6 months) | No Evidence Yet | N/A |
| People with oral submucous fibrosis | Hydrocortisone + hyaluronidase | Placebo | Interincisal distance (< 3 months) | No Evidence Yet | N/A |
| People with oral submucous fibrosis | Hydrocortisone + hyaluronidase | Placebo | Adverse effects | No Evidence Yet | N/A |
| People with oral submucous fibrosis | Hydrocortisone + hyaluronidase | Placebo | Burning sensation | No Evidence Yet | N/A |
| People with oral submucous fibrosis | Pentoxifylline | Placebo | Burning sensation (> 6 months) | No Evidence Yet | N/A |
| People with oral submucous fibrosis | Pentoxifylline | Placebo | Adverse effects | No Evidence Yet | N/A |
| People with oral submucous fibrosis | Pentoxifylline | Placebo | Burning sensation (< 3 months) | No Evidence Yet | N/A |
| People with oral submucous fibrosis | Pentoxifylline | Placebo | Interincisal distance (> 6 months) | No Evidence Yet | N/A |
| People with oral submucous fibrosis | Physiotherapy | No active treatment | Adverse effects | No Evidence Yet | N/A |
| People with oral submucous fibrosis | Physiotherapy | No active treatment | Interincisal distance (< 3 months) | No Evidence Yet | N/A |
| People with oral submucous fibrosis | Physiotherapy | No active treatment | Interincisal distance (> 6 months) | No Evidence Yet | N/A |
| People with oral submucous fibrosis | Physiotherapy | No active treatment | Burning sensation | No Evidence Yet | N/A |
| People with oral submucous fibrosis | Vasodilator | Placebo | Interincisal distance (> 6 months) | No Evidence Yet | N/A |
| People with oral submucous fibrosis | Vasodilator | Placebo | Adverse effects | No Evidence Yet | N/A |
| People with oral submucous fibrosis | Vasodilator | Placebo | Burning sensation (> 6 months) | No Evidence Yet | N/A |
| People with oral submucous fibrosis | Dexamethasone | Placebo | Burning sensation (3-6 months) | Very Low | Not specified |
| People with oral submucous fibrosis | Dexamethasone | Placebo | Interincisal distance (< 3 months) | Very Low | Not specified |
| People with oral submucous fibrosis | Dexamethasone | Placebo | Interincisal distance (3-6 months) | Very Low | Not specified |
| People with oral submucous fibrosis | Dexamethasone | Placebo | Burning sensation (< 3 months) | Very Low | Not specified |
| People with oral submucous fibrosis | Hydrocortisone + hyaluronidase | Placebo | Interincisal distance (3-6 months) | Very Low | Not specified |
| People with oral submucous fibrosis | Pentoxifylline | Placebo | Interincisal distance (3-6 months) | Very Low | Not specified |
| People with oral submucous fibrosis | Pentoxifylline | Placebo | Burning sensation (3-6 months) | Very Low | Not specified |
| People with oral submucous fibrosis | Physiotherapy | No active treatment | Interincisal distance (3-6 months) | Very Low | Not specified |
| People with oral submucous fibrosis | Vasodilator | Placebo | Burning sensation (< 3 months) | Very Low | Not specified |
| People with oral submucous fibrosis | Vasodilator | Placebo | Burning sensation (3-6 months) | Very Low | Not specified |
| People with oral submucous fibrosis | Vasodilator | Placebo | Interincisal distance (3-6 months) | Very Low | Not specified |
| People with oral submucous fibrosis | Vasodilator | Placebo | Interincisal distance (< 3 months) | Very Low | Not specified |
Previous Versions
CD007156.PUB2
| Population | Intervention | Comparison | Outcome | Evidence Level | Studies |
|---|---|---|---|---|---|
| Adults with oral submucous fibrosis | Lycopene | Placebo | Maximal jaw opening | No Evidence Yet | - |
| Adults with oral submucous fibrosis | Lycopene + intralesional steroids | Placebo | Maximal jaw opening | No Evidence Yet | - |
| Adults with oral submucous fibrosis | Pentoxifylline | Multivitamin | Burning sensation | No Evidence Yet | - |
| Adults with oral submucous fibrosis | Pentoxifylline | Multivitamin | Maximal jaw opening | No Evidence Yet | - |
CD007157
Current Version: CD007157.PUB2
Current Evidence Gaps 1 gap
| Population | Intervention | Comparison | Outcome | Evidence Level | Downgrade Reason |
|---|---|---|---|---|---|
| Patients with amelogenesis imperfecta | Restorative treatments | nan | nan | No Evidence Yet | N/A |
CD007158
Current Version: CD007158.PUB2
Current Evidence Gaps 1 gap
| Population | Intervention | Comparison | Outcome | Evidence Level | Downgrade Reason |
|---|---|---|---|---|---|
| Patients requiring facial fracture fixation | Resorbable fixation systems | Titanium fixation systems | nan | No Evidence Yet | N/A |
CD007161
Current Version: CD007161.PUB3
| 1 older version
Current Evidence Gaps 29 gaps
| Population | Intervention | Comparison | Outcome | Evidence Level | Downgrade Reason |
|---|---|---|---|---|---|
| Adult patients with single recession-type defects | ADMG + CAF | CAF | Clinical attachment level change | Low | Not specified |
| Adult patients with single recession-type defects | ADMG + CAF | SCTG + CAF | Sites with complete root coverage | Low | Not specified |
| Adult patients with single recession-type defects | ADMG + CAF | SCTG + CAF | Gingival recession change | Low | Not specified |
| Adult patients with single recession-type defects | ADMG + CAF | SCTG + CAF | Clinical attachment level change | Low | Not specified |
| Adult patients with single recession-type defects | ADMG + CAF | CAF | Gingival recession depth change | Low | Not specified |
| Adult patients with single recession-type defects | ADMG + CAF | CAF | Keratinized tissue width change | Low | Not specified |
| Adult patients with single recession-type defects | EMP + CAF | SCTG + CAF | Clinical attachment change | Low | Not specified |
| Adult patients with single recession-type defects | EMP + CAF | CAF | Keratinized tissue width change | Low | Not specified |
| Adult patients with single recession-type defects | EMP + CAF | CAF | Gingival recession depth change | Low | Not specified |
| Adult patients with single recession-type defects | EMP + CAF | CAF | Clinical attachment level change | Low | Not specified |
| Adult patients with single recession-type defects | GTR rm + CAF | SCTG + CAF | Clinical attachment level change | Low | Not specified |
| Adult patients with single recession-type defects | GTR rm + CAF | SCTG + CAF | Gingival recession change | Low | Not specified |
| Adult patients with single recession-type defects | GTR rm + CAF | SCTG + CAF | Sites with complete root coverage | Low | Not specified |
| Adult patients with single recession-type defects | XCM + CAF | CAF | Keratinized tissue width change | Low | Not specified |
| Adult patients with single recession-type defects | XCM + CAF | CAF | Gingival recession depth change | Low | Not specified |
| Adult patients with single recession-type defects | XCM + CAF | CAF | Clinical attachment level change | Low | Not specified |
| Adult patients with single recession-type defects | XCM + CAF | CAF | Sites with complete root coverage | Low | Not specified |
| Adult patients with single recession-type defects | XCM + CAF | CAF | Aesthetic condition change related to patient's opinion | Low | Not specified |
| Adult patients with single recession-type defects | ADMG + CAF | SCTG + CAF | Aesthetic condition change related to patient's opinion | No Evidence Yet | N/A |
| Adult patients with single recession-type defects | ADMG + CAF | CAF | Aesthetic condition change related to patient's opinion | No Evidence Yet | N/A |
| Adult patients with single recession-type defects | EMP + CAF | CAF | Aesthetic condition change related to patient's opinion | No Evidence Yet | N/A |
| Adult patients with single recession-type defects | GTR rm + CAF | SCTG + CAF | Aesthetic condition change related to patient's opinion | No Evidence Yet | N/A |
| Adult patients with single recession-type defects | ADMG + CAF | CAF | Sites with complete root coverage | Very Low | Not specified |
| Adult patients with single recession-type defects | ADMG + CAF | SCTG + CAF | Keratinized tissue change | Very Low | Not specified |
| Adult patients with single recession-type defects | EMP + CAF | SCTG + CAF | Sites with complete root coverage | Very Low | Not specified |
| Adult patients with single recession-type defects | EMP + CAF | SCTG + CAF | Keratinized tissue change | Very Low | Not specified |
| Adult patients with single recession-type defects | EMP + CAF | SCTG + CAF | Gingival recession change | Very Low | Not specified |
| Adult patients with single recession-type defects | EMP + CAF | SCTG + CAF | Aesthetic condition change related to patient's opinion | Very Low | Not specified |
| Adult patients with single recession-type defects | GTR rm + CAF | SCTG + CAF | Keratinized tissue change | Very Low | Not specified |
Previous Versions
CD007161.PUB2
| Population | Intervention | Comparison | Outcome | Evidence Level | Studies |
|---|---|---|---|---|---|
| Patients with gingival recession | ADMG | SCTG | Gingival recession change | No Evidence Yet | - |
| Patients with gingival recession | ADMG | CAF | Keratinized tissue change | No Evidence Yet | - |
| Patients with gingival recession | ADMG | CAF | Clinical attachment level change | No Evidence Yet | - |
| Patients with gingival recession | ADMG | CAF | Gingival recession change | No Evidence Yet | - |
| Patients with gingival recession | ADMG | SCTG | Keratinized tissue change | No Evidence Yet | - |
| Patients with gingival recession | ADMG | SCTG | Clinical attachment level change | No Evidence Yet | - |
| Patients with gingival recession | EMP+CAF | CAF | Keratinized tissue change | No Evidence Yet | - |
| Patients with gingival recession | EMP+CAF | CAF | Clinical attachment level change | No Evidence Yet | - |
| Patients with gingival recession | EMP+CAF | CAF | Gingival recession change | No Evidence Yet | - |
| Patients with gingival recession | GTR rm | SCTG | Complete root coverage | No Evidence Yet | - |
| Patients with gingival recession | GTR rm | SCTG | Keratinized tissue change | No Evidence Yet | - |
| Patients with gingival recession | GTR rm | SCTG | Clinical attachment level change | No Evidence Yet | - |
| Patients with gingival recession | GTR rm | SCTG | Gingival recession change | No Evidence Yet | - |
| Patients with gingival recession | GTR rm | GTR nrm | Keratinized tissue change | No Evidence Yet | - |
| Patients with gingival recession | GTR rm | GTR nrm | Clinical attachment level change | No Evidence Yet | - |
| Patients with gingival recession | GTR rm | GTR nrm | Gingival recession change | No Evidence Yet | - |
| Patients with gingival recession | GTR rm+bone substitutes | GTR rm | Keratinized tissue change | No Evidence Yet | - |
| Patients with gingival recession | GTR rm+bone substitutes | GTR rm | Clinical attachment level change | No Evidence Yet | - |
| Patients with gingival recession | GTR rm+bone substitutes | GTR rm | Gingival recession change | No Evidence Yet | - |
| Patients with gingival recession | GTR rm+bone substitutes | SCTG | Keratinized tissue change | No Evidence Yet | - |
| Patients with gingival recession | GTR rm+bone substitutes | SCTG | Gingival recession change | No Evidence Yet | - |
CD007261
Current Version: CD007261.PUB2
Current Evidence Gaps 14 gaps
| Population | Intervention | Comparison | Outcome | Evidence Level | Downgrade Reason |
|---|---|---|---|---|---|
| TMJ osteoarthritis | Diclofenac sodium | Occlusal splint | Complications | No Evidence Yet | N/A |
| TMJ osteoarthritis | Glucosamine sulfate | Ibuprofen | Masticatory muscle tenderness | No Evidence Yet | N/A |
| TMJ osteoarthritis | Glucosamine sulfate | Ibuprofen | BPI pain interference | No Evidence Yet | N/A |
| TMJ osteoarthritis | Glucosamine sulfate | Ibuprofen | BPI pain intensity | No Evidence Yet | N/A |
| TMJ osteoarthritis | Glucosamine sulfate | Ibuprofen | Maximum voluntary jaw opening | No Evidence Yet | N/A |
| TMJ osteoarthritis | Glucosamine sulfate | Ibuprofen | Pain-free jaw opening | No Evidence Yet | N/A |
| TMJ osteoarthritis | Glucosamine sulfate | Ibuprofen | Reported pain at 90 days | No Evidence Yet | N/A |
| TMJ osteoarthritis | Sodium hyaluronate | Corticosteroids | Reported pain at 6 months | No Evidence Yet | N/A |
| TMJ osteoarthritis | Sodium hyaluronate | Corticosteroids | Complications | No Evidence Yet | N/A |
| TMJ osteoarthritis | Sodium hyaluronate | Corticosteroids | TMJ sounds at 6 months | No Evidence Yet | N/A |
| TMJ osteoarthritis | Sodium hyaluronate | Corticosteroids | TMJ sounds at 1 month | No Evidence Yet | N/A |
| TMJ osteoarthritis | Sodium hyaluronate | Corticosteroids | TMJ sounds at 14 days | No Evidence Yet | N/A |
| TMJ osteoarthritis | Sodium hyaluronate | Corticosteroids | Reported pain at 1 month | No Evidence Yet | N/A |
| TMJ osteoarthritis | Sodium hyaluronate | Corticosteroids | Reported pain at 14 days | No Evidence Yet | N/A |
CD007395
Current Version: CD007395.PUB2
Current Evidence Gaps 15 gaps
| Population | Intervention | Comparison | Outcome | Evidence Level | Downgrade Reason |
|---|---|---|---|---|---|
| Complete denture wearers | Brushing | No treatment | Fusobacteria count | No Evidence Yet | N/A |
| Complete denture wearers | Brushing | Effervescent tablets | Total anaerobes count | No Evidence Yet | N/A |
| Complete denture wearers | Brushing | Effervescent tablets | Fusobacteria count | No Evidence Yet | N/A |
| Complete denture wearers | Brushing | No treatment | Total anaerobes count | No Evidence Yet | N/A |
| Complete denture wearers | Combined (brushing + effervescent) | Brushing | Fusobacteria count | No Evidence Yet | N/A |
| Complete denture wearers | Combined (brushing + effervescent) | No treatment | Total anaerobes count | No Evidence Yet | N/A |
| Complete denture wearers | Combined (brushing + effervescent) | No treatment | Fusobacteria count | No Evidence Yet | N/A |
| Complete denture wearers | Combined (brushing + effervescent) | Effervescent tablets | Fusobacteria count | No Evidence Yet | N/A |
| Complete denture wearers | Combined (brushing + effervescent) | Brushing | Total anaerobes count | No Evidence Yet | N/A |
| Complete denture wearers | Combined (brushing + effervescent) | Effervescent tablets | Total anaerobes count | No Evidence Yet | N/A |
| Complete denture wearers | Effervescent tablets | No treatment | Total anaerobes count | No Evidence Yet | N/A |
| Complete denture wearers | Effervescent tablets | No treatment | Fusobacteria count | No Evidence Yet | N/A |
| Complete denture wearers | Enzyme cleanser | Placebo | Caregiver-perceived improvement in denture cleanliness | No Evidence Yet | N/A |
| Complete denture wearers | Silicone cleanser | Placebo | Visual plaque score (14 days) | No Evidence Yet | N/A |
| Complete denture wearers | Silicone cleanser | Placebo | Visual plaque score (2 days) | No Evidence Yet | N/A |
CD007404
Current Version: CD007404.PUB2
Current Evidence Gaps 1 gap
| Population | Intervention | Comparison | Outcome | Evidence Level | Downgrade Reason |
|---|---|---|---|---|---|
| Patients with histologically confirmed central giant cell granuloma in jaws with normal calcium and PTH serum levels | Salmon calcitonin nasal spray 200 IU/day | Placebo | Proportion of patients with increased lesion volume >10% | No Evidence Yet | N/A |
CD007447
Current Version: CD007447.PUB2
Current Evidence Gaps 12 gaps
| Population | Intervention | Comparison | Outcome | Evidence Level | Downgrade Reason |
|---|---|---|---|---|---|
| Children or adults | Any form of 1-to-1 OHA | No OHA | Periodontal health: plaque levels | Low | Not specified |
| Children or adults | Self-management | Professional OHA | Dental caries | No Evidence Yet | N/A |
| Children or adults | Any form of 1-to-1 OHA | No OHA | Periodontal health: gingivitis | Very Low | Not specified |
| Children or adults | Any form of 1-to-1 OHA | No OHA | Dental caries | Very Low | Not specified |
| Children or adults | Enhanced 1-to-1 OHA | 1-to-1 OHA | Dental caries | Very Low | Not specified |
| Children or adults | Enhanced 1-to-1 OHA | 1-to-1 OHA | Periodontal health: gingivitis | Very Low | Not specified |
| Children or adults | Enhanced 1-to-1 OHA | 1-to-1 OHA | Periodontal health: plaque levels | Very Low | Not specified |
| Children or adults | Personalised 1-to-1 OHA | Routine 1-to-1 OHA | Dental caries | Very Low | Not specified |
| Children or adults | Personalised 1-to-1 OHA | Routine 1-to-1 OHA | Periodontal health: gingivitis | Very Low | Not specified |
| Children or adults | Personalised 1-to-1 OHA | Routine 1-to-1 OHA | Periodontal health: plaque levels | Very Low | Not specified |
| Children or adults | Self-management | Professional OHA | Periodontal health: plaque levels | Very Low | Not specified |
| Children or adults | Self-management | Professional OHA | Periodontal health: gingivitis | Very Low | Not specified |
CD007517
Current Version: CD007517.PUB3
| 1 older version
Current Evidence Gaps 6 gaps
| Population | Intervention | Comparison | Outcome | Evidence Level | Downgrade Reason |
|---|---|---|---|---|---|
| Patients with restorations of dental amalgam | Adhesive bonding | Control | Marginal deterioration of the restoration and fracture of the remaining tooth tissue | Low | Not specified |
| Patients with restorations of dental amalgam | Adhesive bonding | Control | Survival of the restoration | Low | Not specified |
| Patients with restorations of dental amalgam | Adhesive bonding | Control | Economic data: direct costs of materials and any reported associated indirect costs | No Evidence Yet | N/A |
| Patients with restorations of dental amalgam | Adhesive bonding | Control | Post-insertion sensitivity or pain assessed by a validated pain scale | No Evidence Yet | N/A |
| Patients with restorations of dental amalgam | Adhesive bonding | Control | Secondary caries, as diagnosed clinically | No Evidence Yet | N/A |
| Patients with restorations of dental amalgam | Adhesive bonding | Control | Adverse effects: any event for which the causal relationship between the event and the amalgam restoration is at least a reasonable possibility | No Evidence Yet | N/A |
Previous Versions
CD007517.PUB2
| Population | Intervention | Comparison | Outcome | Evidence Level | Studies |
|---|---|---|---|---|---|
| Patients requiring Class II restorations in vital posterior teeth | Adhesively bonded amalgam | Non-bonded amalgam | Marginal adaptation - Occlusal at baseline | No Evidence Yet | - |
| Patients requiring Class II restorations in vital posterior teeth | Adhesively bonded amalgam | Non-bonded amalgam | Restoration failure at 24 months | No Evidence Yet | - |
| Patients requiring Class II restorations in vital posterior teeth | Adhesively bonded amalgam | Non-bonded amalgam | Marginal adaptation - Proximal at 24 months | No Evidence Yet | - |
| Patients requiring Class II restorations in vital posterior teeth | Adhesively bonded amalgam | Non-bonded amalgam | Marginal adaptation - Proximal at baseline | No Evidence Yet | - |
| Patients requiring Class II restorations in vital posterior teeth | Adhesively bonded amalgam | Non-bonded amalgam | Marginal adaptation - Occlusal at 24 months | No Evidence Yet | - |
CD007592
Current Version: CD007592.PUB2
Current Evidence Gaps 5 gaps
| Population | Intervention | Comparison | Outcome | Evidence Level | Downgrade Reason |
|---|---|---|---|---|---|
| Children and adolescents | Fluoride supplements | Other preventive measures | Caries increment on permanent tooth surfaces | Low | Not specified |
| Children and adolescents | Fluoride supplements | Topical fluoride | Caries increment on permanent tooth surfaces | Moderate | Not specified |
| Children and adolescents | Fluoride supplements | Topical fluoride | Caries increment on deciduous tooth surfaces | Moderate | Not specified |
| Children and adolescents | Fluoride supplements | No fluoride supplement | Caries increment on permanent tooth surfaces | Moderate | Not specified |
| Children and adolescents | Fluoride supplements | No fluoride supplement | Caries increment in permanent teeth | Moderate | Not specified |
| Children and adolescents | Fluoride supplements | Topical fluoride | Fluorosis (adverse effect) | No Evidence Yet | N/A |
| Children and adolescents | Fluoride supplements | No fluoride supplement | Caries increment in deciduous teeth | Very Low | Not specified |
| Children and adolescents | Fluoride supplements | No fluoride supplement | Caries increment on deciduous tooth surfaces | Very Low | Not specified |
| Children and adolescents | Fluoride supplements | No fluoride supplement | Fluorosis (adverse effect) | Very Low | Not specified |
CD007693
Current Version: CD007693.PUB2
Current Evidence Gaps 7 gaps
| Population | Intervention | Comparison | Outcome | Evidence Level | Downgrade Reason |
|---|---|---|---|---|---|
| Children under 6 years | Brushing after 12-14 months | Brushing before 12-14 months | Fluorosis (cross-sectional) | No Evidence Yet | N/A |
| Children under 6 years | Brushing after 24 months | Brushing before 24 months | Fluorosis (cross-sectional) | No Evidence Yet | N/A |
| Children under 6 years | Brushing after 24 months | Brushing before 24 months | Fluorosis (case-control studies) | No Evidence Yet | N/A |
| Children under 6 years | Less frequent brushing (<2x/day) | More frequent brushing (≥2x/day) | Fluorosis | No Evidence Yet | N/A |
| Children under 6 years | Lower fluoride toothpaste (250-550 ppm) | Higher fluoride toothpaste (>1000 ppm) | Fluorosis (cross-sectional) | No Evidence Yet | N/A |
| Children under 6 years | Lower fluoride toothpaste (440-550 ppm) | Higher fluoride toothpaste (1000-1450 ppm) | Fluorosis (RCTs) | No Evidence Yet | N/A |
| Children under 6 years | Small/pea-size amount | Medium/large amount | Fluorosis | No Evidence Yet | N/A |
CD007819
Current Version: CD007819.PUB3
| 1 older version
Current Evidence Gaps 1 gap
| Population | Intervention | Comparison | Outcome | Evidence Level | Downgrade Reason |
|---|---|---|---|---|---|
| Dental patients | Antibacterial containing composites | Other active interventions or controls | nan | No Evidence Yet | N/A |
Previous Versions
CD007819.PUB2
| Population | Intervention | Comparison | Outcome | Evidence Level | Studies |
|---|---|---|---|---|---|
| nan | nan | nan | nan | No Evidence Yet | - |
CD007820
Current Version: CD007820.PUB3
| 1 older version
Current Evidence Gaps 1 gap
| Population | Intervention | Comparison | Outcome | Evidence Level | Downgrade Reason |
|---|---|---|---|---|---|
| nan | nan | nan | nan | No Evidence Yet | N/A |
Previous Versions
CD007820.PUB2
| Population | Intervention | Comparison | Outcome | Evidence Level | Studies |
|---|---|---|---|---|---|
| nan | nan | nan | nan | No Evidence Yet | - |
CD007859
Current Version: CD007859.PUB5
| 3 older versions
Current Evidence Gaps 22 gaps
| Population | Intervention | Comparison | Outcome | Evidence Level | Downgrade Reason |
|---|---|---|---|---|---|
| People receiving orthodontic treatment with fixed appliances | Conventional NiTi wire | Thermoelastic CuNiTi wire | Time to alignment | Low | Not specified |
| People receiving orthodontic treatment with fixed appliances | Conventional NiTi wire | Superelastic NiTi wire | Alignment rate | Low | Not specified |
| People receiving orthodontic treatment with fixed appliances | Conventional NiTi wire | Superelastic NiTi wire | Pain | Low | Not specified |
| People receiving orthodontic treatment with fixed appliances | Different sizes of nickel-titanium wires | Different sizes of nickel-titanium wires | Pain | Low | Not specified |
| People receiving orthodontic treatment with fixed appliances | Multistrand stainless steel wire | Wire composed of other materials (conventional StSt, superelastic nickelâtitanium, thermoelastic nickelâtitanium) | Pain | Low | Not specified |
| People receiving orthodontic treatment with fixed appliances | Superelastic NiTi wire | Thermoelastic NiTi wire | Time to alignment | Low | Not specified |
| People receiving orthodontic treatment with fixed appliances | Superelastic NiTi wire | Thermoelastic NiTi wire | Alignment rate | Low | Not specified |
| People receiving orthodontic treatment with fixed appliances | Single-strand superelastic NiTi wire | Coaxial superelastic NiTi wire | Alignment rate | Moderate | Not specified |
| People receiving orthodontic treatment with fixed appliances | Superelastic NiTi wire | Thermoelastic NiTi wire | Pain | Moderate | Not specified |
| People receiving orthodontic treatment with fixed appliances | Conventional NiTi wire | Superelastic NiTi wire | Time to alignment | No Evidence Yet | N/A |
| People receiving orthodontic treatment with fixed appliances | Conventional NiTi wire | Thermoelastic CuNiTi wire | Pain | No Evidence Yet | N/A |
| People receiving orthodontic treatment with fixed appliances | Conventional NiTi wire | Thermoelastic CuNiTi wire | Root resorption | No Evidence Yet | N/A |
| People receiving orthodontic treatment with fixed appliances | Conventional NiTi wire | Superelastic NiTi wire | Root resorption | No Evidence Yet | N/A |
| People receiving orthodontic treatment with fixed appliances | Different sizes of nickel-titanium wires | Different sizes of nickel-titanium wires | Root resorption | No Evidence Yet | N/A |
| People receiving orthodontic treatment with fixed appliances | Different sizes of nickel-titanium wires | Different sizes of nickel-titanium wires | Alignment rate | No Evidence Yet | N/A |
| People receiving orthodontic treatment with fixed appliances | Different sizes of nickel-titanium wires | Different sizes of nickel-titanium wires | Time to alignment | No Evidence Yet | N/A |
| People receiving orthodontic treatment with fixed appliances | Multistrand stainless steel wire | Wire composed of other materials (conventional StSt, superelastic nickelâtitanium, thermoelastic nickelâtitanium) | Time to alignment | No Evidence Yet | N/A |
| People receiving orthodontic treatment with fixed appliances | Multistrand stainless steel wire | Wire composed of other materials (conventional StSt, superelastic nickelâtitanium, thermoelastic nickelâtitanium) | Root resorption | No Evidence Yet | N/A |
| People receiving orthodontic treatment with fixed appliances | Single-strand superelastic NiTi wire | Coaxial superelastic NiTi wire | Root resorption | No Evidence Yet | N/A |
| People receiving orthodontic treatment with fixed appliances | Single-strand superelastic NiTi wire | Coaxial superelastic NiTi wire | Pain | No Evidence Yet | N/A |
| People receiving orthodontic treatment with fixed appliances | Single-strand superelastic NiTi wire | Coaxial superelastic NiTi wire | Time to alignment | No Evidence Yet | N/A |
| People receiving orthodontic treatment with fixed appliances | Conventional NiTi wire | Thermoelastic CuNiTi wire | Alignment rate | Very Low | Not specified |
| People receiving orthodontic treatment with fixed appliances | Multistrand stainless steel wire | Wire composed of other materials (conventional StSt, superelastic nickelâtitanium, thermoelastic nickelâtitanium) | Alignment rate | Very Low | Not specified |
| People receiving orthodontic treatment with fixed appliances | Superelastic NiTi wire | Thermoelastic NiTi wire | Root resorption | Very Low | Not specified |
Previous Versions
CD007859.PUB4
| Population | Intervention | Comparison | Outcome | Evidence Level | Studies |
|---|---|---|---|---|---|
| people receiving orthodontic treatment with fixed appliances | superelastic NiTi | multistrand stainless steel | Alignment rate between first molars | Low | - |
| people receiving orthodontic treatment with fixed appliances | superelastic NiTi | conventional NiTi | Time to alignment | Low | - |
| people receiving orthodontic treatment with fixed appliances | thermoelastic NiTi | multistrand stainless steel | Alignment rate between first molars | Low | - |
| people receiving orthodontic treatment with fixed appliances | thermoelastic NiTi | superelastic NiTi | Alignment rate between first molars | Low | - |
| people receiving orthodontic treatment with fixed appliances | thermoelastic NiTi | superelastic NiTi | Time to alignment | Low | - |
| people receiving orthodontic treatment with fixed appliances | thermoelastic NiTi | superelastic NiTi | Pain day 1 | Low | - |
| people receiving orthodontic treatment with fixed appliances | coaxial superelastic NiTi | single-strand superelastic NiTi | Alignment rate between canines | Moderate | - |
| people receiving orthodontic treatment with fixed appliances | superelastic NiTi | multistrand stainless steel | Pain day 1 | Moderate | - |
| people receiving orthodontic treatment with fixed appliances | coaxial superelastic NiTi | single-strand superelastic NiTi | Root resorption | No Evidence Yet | - |
| people receiving orthodontic treatment with fixed appliances | coaxial superelastic NiTi | single-strand superelastic NiTi | Pain | No Evidence Yet | - |
| people receiving orthodontic treatment with fixed appliances | coaxial superelastic NiTi | single-strand superelastic NiTi | Time to alignment | No Evidence Yet | - |
| people receiving orthodontic treatment with fixed appliances | superelastic NiTi | multistrand stainless steel | Root resorption | No Evidence Yet | - |
| people receiving orthodontic treatment with fixed appliances | superelastic NiTi | multistrand stainless steel | Time to alignment | No Evidence Yet | - |
| people receiving orthodontic treatment with fixed appliances | superelastic NiTi | conventional NiTi | Root resorption | No Evidence Yet | - |
| people receiving orthodontic treatment with fixed appliances | thermoelastic NiTi | superelastic NiTi | Root resorption | No Evidence Yet | - |
| people receiving orthodontic treatment with fixed appliances | thermoelastic NiTi | multistrand stainless steel | Time to alignment | No Evidence Yet | - |
| people receiving orthodontic treatment with fixed appliances | thermoelastic NiTi | multistrand stainless steel | Pain | No Evidence Yet | - |
| people receiving orthodontic treatment with fixed appliances | thermoelastic NiTi | multistrand stainless steel | Root resorption | No Evidence Yet | - |
| people receiving orthodontic treatment with fixed appliances | superelastic NiTi | conventional NiTi | Alignment rate between canines | Very Low | - |
| people receiving orthodontic treatment with fixed appliances | superelastic NiTi | conventional NiTi | Pain day 1 | Very Low | - |
CD007859.PUB3
| Population | Intervention | Comparison | Outcome | Evidence Level | Studies |
|---|---|---|---|---|---|
| Adolescents undergoing orthodontic treatment - initial alignment phase | Nickel titanium arch wires | Multistrand stainless steel initial arch wires | Tooth movement | Low | - |
| Adolescents undergoing orthodontic treatment - initial alignment phase | Either coaxial copper nickel titanium or thermoelastic nickel titanium arch wire | Single-strand superelastic nickel titanium arch wire | Root Resorption | No Evidence Yet | - |
| Adolescents undergoing orthodontic treatment - initial alignment phase | Nickel titanium arch wires | Multistrand stainless steel initial arch wires | Root resorption | No Evidence Yet | - |
| Adolescents undergoing orthodontic treatment - initial alignment phase | Superelastic nickel titanium arch wires | Conventional (stabilised) nickel titanium arch wires | Root resorption | No Evidence Yet | - |
| Adolescents undergoing orthodontic treatment - initial alignment phase | Coaxial nickel titanium arch wire | Single-strand superelastic nickel titanium arch wire | Alignment (mm/12 weeks) | Very Low | - |
| Adolescents undergoing orthodontic treatment - initial alignment phase | Copper nickel titanium arch wire | Single-strand superelastic nickel titanium arch wire | Alignment rate ratio | Very Low | - |
| Adolescents undergoing orthodontic treatment - initial alignment phase | Nickel titanium arch wires | Multistrand stainless steel initial arch wires | Pain (VAS) day 1 or day 7 | Very Low | - |
| Adolescents undergoing orthodontic treatment - initial alignment phase | Superelastic nickel titanium arch wires | Conventional (stabilised) nickel titanium arch wires | Pain (VAS) day 1 | Very Low | - |
| Adolescents undergoing orthodontic treatment - initial alignment phase | Superelastic nickel titanium arch wires | Conventional (stabilised) nickel titanium arch wires | Tooth movement | Very Low | - |
| Adolescents undergoing orthodontic treatment - initial alignment phase | Thermoelastic nickel titanium arch wire | Single-strand superelastic nickel titanium arch wire | Pain (VAS) day 1 & day 7 | Very Low | - |
CD007859.PUB2
| Population | Intervention | Comparison | Outcome | Evidence Level | Studies |
|---|---|---|---|---|---|
| Patients with full arch fixed orthodontic appliances | 0.014 inch superelastic NiTi wire | 0.015 inch multistrand stainless steel wire | Pain intensity (3rd day) | Low | - |
| Patients with full arch fixed orthodontic appliances | 0.014 inch superelastic NiTi wire | 0.015 inch multistrand stainless steel wire | Pain intensity (over 14 days) | Low | - |
| Patients with full arch fixed orthodontic appliances | 0.014 inch superelastic NiTi wire | 0.015 inch multistrand stainless steel wire | Pain intensity (7th day) | Low | - |
| Patients with full arch fixed orthodontic appliances | 0.014 inch superelastic NiTi wire | 0.015 inch multistrand stainless steel wire | Pain intensity (6th day) | Low | - |
| Patients with full arch fixed orthodontic appliances | 0.014 inch superelastic NiTi wire | 0.015 inch multistrand stainless steel wire | Pain intensity (5th day) | Low | - |
| Patients with full arch fixed orthodontic appliances | 0.014 inch superelastic NiTi wire | 0.015 inch multistrand stainless steel wire | Pain intensity (4th day) | Low | - |
| Patients with full arch fixed orthodontic appliances | 0.014 inch superelastic NiTi wire | 0.015 inch multistrand stainless steel wire | Pain intensity (2nd day) | Low | - |
| Patients with full arch fixed orthodontic appliances | 0.014 inch superelastic NiTi wire | 0.015 inch multistrand stainless steel wire | Pain intensity (1st day) | Low | - |
| Patients with full arch fixed orthodontic appliances | 0.014 inch superelastic NiTi wire | 0.014 inch NiTi wire | Pain intensity (3rd day) | Moderate | - |
| Patients with full arch fixed orthodontic appliances | 0.014 inch superelastic NiTi wire | 0.014 inch NiTi wire | Pain intensity (2nd day) | Moderate | - |
| Patients with full arch fixed orthodontic appliances | 0.014 inch superelastic NiTi wire | 0.014 inch NiTi wire | Pain intensity (7th day) | Moderate | - |
| Patients with full arch fixed orthodontic appliances | 0.014 inch superelastic NiTi wire | 0.014 inch NiTi wire | Pain intensity (6th day) | Moderate | - |
| Patients with full arch fixed orthodontic appliances | 0.014 inch superelastic NiTi wire | 0.014 inch NiTi wire | Pain intensity (5th day) | Moderate | - |
| Patients with full arch fixed orthodontic appliances | 0.014 inch superelastic NiTi wire | 0.014 inch NiTi wire | Pain intensity (4th day) | Moderate | - |
| Patients with full arch fixed orthodontic appliances | 0.016 inch CuNiTi wire | 0.016 inch NiTi wire | Time to alignment of the lower anterior dental arches (days) | Moderate | - |
| Patients with full arch fixed orthodontic appliances | 0.016 inch superelastic NiTi wire | 0.016 inch NiTi wire | Alignment rate (contact point movement) | Moderate | - |
CD007868
Current Version: CD007868.PUB3
| 1 older version
Current Evidence Gaps 36 gaps
| Population | Intervention | Comparison | Outcome | Evidence Level | Downgrade Reason |
|---|---|---|---|---|---|
| Adults aged between 18 and 93 years of age at the start of the study | 1000 or 1100 ppm F toothpaste | 0 ppm F toothpaste | Caries increment (tooth index D3MFT) | Low | Not specified |
| Children and adolescents between 5 and 15 years of age at the start of the study | 1000 to 1250 ppm F toothpaste | 0 ppm F toothpaste | Proportion of children developing new caries | Low | Not specified |
| Children and adolescents between 5 and 15 years of age at the start of the study | 1450 to 1500 ppm F toothpaste | 1000 to 1250 ppm F toothpaste | Proportion of children developing new caries | Low | Not specified |
| Children and adolescents between 5 and 15 years of age at the start of the study | 1500 ppm F toothpaste | 0 ppm F toothpaste | Proportion of children developing new caries | Low | Not specified |
| Children and adolescents between 5 and 15 years of age at the start of the study | 250 ppm F toothpaste | 0 ppm F toothpaste | Proportion of children developing new caries | Low | Not specified |
| Young children between 1 and 6 years of age at the start of the study | 1055 to 1100 ppm F toothpaste | 500 to 550 ppm F toothpaste | Adverse effects of toothpaste | Low | Not specified |
| Young children between 1 and 6 years of age at the start of the study | 1055 to 1100 ppm F toothpaste | 500 to 550 ppm F toothpaste | Caries increment (tooth index d3mft) | Low | Not specified |
| Young children between 1 and 6 years of age at the start of the study | 1055 to 1100 ppm F toothpaste | 500 to 550 ppm F toothpaste | Proportion of children developing new caries | Low | Not specified |
| Young children between 1 and 6 years of age at the start of the study | 1450 ppm F toothpaste | 250 ppm F toothpaste | Caries increment (surface index d3mfs) | Low | Not specified |
| Young children between 1 and 6 years of age at the start of the study | 1450 ppm F toothpaste | 250 ppm F toothpaste | Proportion of children developing new caries | Low | Not specified |
| Young children between 1 and 6 years of age at the start of the study | 1450 ppm F toothpaste | 250 ppm F toothpaste | Caries increment (tooth index d3mft) | Low | Not specified |
| Young children between 1 and 6 years of age at the start of the study | 1500 ppm F toothpaste | 0 ppm F toothpaste | Adverse effects of toothpaste | Low | Not specified |
| Adults aged between 18 and 93 years of age at the start of the study | 1000 or 1100 ppm F toothpaste | 0 ppm F toothpaste | Caries increment (surface index D3MFS) | Moderate | Not specified |
| Young children between 1 and 6 years of age at the start of the study | 1055 to 1100 ppm F toothpaste | 500 to 550 ppm F toothpaste | Caries increment (surface index d3mfs) | Moderate | Not specified |
| Young children between 1 and 6 years of age at the start of the study | 1450 F toothpaste | 440 ppm F toothpaste | Caries increment (tooth index d3mft) | Moderate | Not specified |
| Young children between 1 and 6 years of age at the start of the study | 1450 F toothpaste | 440 ppm F toothpaste | Proportion developing new caries | Moderate | Not specified |
| Young children between 1 and 6 years of age at the start of the study | 1500 ppm F toothpaste | 0 ppm F toothpaste | Caries increment (surface index d3fs) | Moderate | Not specified |
| Adults aged between 18 and 93 years of age at the start of the study | 1000 or 1100 ppm F toothpaste | 0 ppm F toothpaste | Proportion of adults developing new caries | No Evidence Yet | N/A |
| Adults aged between 18 and 93 years of age at the start of the study | 1000 or 1100 ppm F toothpaste | 0 ppm F toothpaste | Adverse effects of toothpaste | No Evidence Yet | N/A |
| Children and adolescents between 5 and 15 years of age at the start of the study | toothbrushing with higher fluoride concentration toothpaste | toothbrushing with lower fluoride concentration toothpaste | Adverse effects of toothpaste | No Evidence Yet | N/A |
| nan | nan | nan | nan | No Evidence Yet | N/A |
| nan | nan | nan | nan | No Evidence Yet | N/A |
| nan | nan | nan | nan | No Evidence Yet | N/A |
| nan | nan | nan | nan | No Evidence Yet | N/A |
| nan | nan | nan | nan | No Evidence Yet | N/A |
| nan | nan | nan | nan | No Evidence Yet | N/A |
| nan | nan | nan | nan | No Evidence Yet | N/A |
| nan | nan | nan | nan | No Evidence Yet | N/A |
| nan | nan | nan | nan | No Evidence Yet | N/A |
| nan | nan | nan | nan | No Evidence Yet | N/A |
| nan | nan | nan | nan | No Evidence Yet | N/A |
| nan | nan | nan | nan | No Evidence Yet | N/A |
| nan | nan | nan | nan | No Evidence Yet | N/A |
| nan | nan | nan | nan | No Evidence Yet | N/A |
| nan | nan | nan | nan | No Evidence Yet | N/A |
| nan | nan | nan | nan | No Evidence Yet | N/A |
| nan | nan | nan | nan | No Evidence Yet | N/A |
| nan | nan | nan | nan | No Evidence Yet | N/A |
| nan | nan | nan | nan | No Evidence Yet | N/A |
| Young children between 1 and 6 years of age at the start of the study | 1450 F toothpaste | 440 ppm F toothpaste | Adverse effects of toothpaste | No Evidence Yet | N/A |
| Young children between 1 and 6 years of age at the start of the study | 1450 ppm F toothpaste | 250 ppm F toothpaste | Adverse effects of toothpaste | No Evidence Yet | N/A |
Previous Versions
CD007868.PUB2
| Population | Intervention | Comparison | Outcome | Evidence Level | Studies |
|---|---|---|---|---|---|
| Children | 1055 ppm F toothpaste | 550 ppm F toothpaste | d(m)fs prevented fraction | No Evidence Yet | - |
| Children | 1450 ppm F toothpaste | 250 ppm F toothpaste | d(m)fs prevented fraction | No Evidence Yet | - |
| Children | 1450 ppm F toothpaste | 440 ppm F toothpaste | d(m)ft prevented fraction | No Evidence Yet | - |
| Children | 1500 ppm F toothpaste | Placebo | d(m)fs prevented fraction | No Evidence Yet | - |
| Children | Higher F concentration | Lower F concentration | Proportion developing new caries (primary teeth) | No Evidence Yet | - |
| Children and adolescents | 1000-1250 ppm F toothpaste | Placebo | D(M)FS prevented fraction | No Evidence Yet | - |
| Children and adolescents | 1000-1250 ppm F toothpaste | Placebo | Proportion developing new caries (permanent teeth) | No Evidence Yet | - |
| Children and adolescents | 1000-1250 ppm F toothpaste | Placebo | D(M)FT prevented fraction | No Evidence Yet | - |
| Children and adolescents | 1450-1500 ppm F toothpaste | Placebo | Proportion developing new caries (permanent teeth) | No Evidence Yet | - |
| Children and adolescents | 2400-2800 ppm F toothpaste | Placebo | D(M)FT prevented fraction | No Evidence Yet | - |
| Children and adolescents | 2400-2800 ppm F toothpaste | Placebo | D(M)FS prevented fraction | No Evidence Yet | - |
CD007975
Current Version: CD007975.PUB2
Current Evidence Gaps 1 gap
| Population | Intervention | Comparison | Outcome | Evidence Level | Downgrade Reason |
|---|---|---|---|---|---|
| nan | Topical treatment | nan | nan | No Evidence Yet | N/A |
CD008001
Current Version: CD008001.PUB2
Current Evidence Gaps 10 gaps
| Population | Intervention | Comparison | Outcome | Evidence Level | Downgrade Reason |
|---|---|---|---|---|---|
| Edentulous adults receiving implant overdentures in one or both jaws to overcome problems with conventional complete dentures | Ball attachment system of mandibular overdentures | Magnetic attachment system of mandibular overdentures | Re-treatment (repair) (medium term) | Very Low | Not specified |
| Edentulous adults receiving implant overdentures in one or both jaws to overcome problems with conventional complete dentures | Ball attachment system of mandibular overdentures | Bar attachment system of mandibular overdentures | Re-treatment (repair) (short term) | Very Low | Not specified |
| Edentulous adults receiving implant overdentures in one or both jaws to overcome problems with conventional complete dentures | Ball attachment system of mandibular overdentures | Magnetic attachment system of mandibular overdentures | Costs (medium term) | Very Low | Not specified |
| Edentulous adults receiving implant overdentures in one or both jaws to overcome problems with conventional complete dentures | Ball attachment system of mandibular overdentures | Bar attachment system of mandibular overdentures | Success (short term) | Very Low | Not specified |
| Edentulous adults receiving implant overdentures in one or both jaws to overcome problems with conventional complete dentures | Ball attachment system of mandibular overdentures | Bar attachment system of mandibular overdentures | Re-treatment (replace) (short term) | Very Low | Not specified |
| Edentulous adults receiving implant overdentures in one or both jaws to overcome problems with conventional complete dentures | Ball attachment system of mandibular overdentures | Magnetic attachment system of mandibular overdentures | Success (medium term) | Very Low | Not specified |
| Edentulous adults receiving implant overdentures in one or both jaws to overcome problems with conventional complete dentures | Ball attachment system of mandibular overdentures | Telescopic attachment system of mandibular overdentures | Reline of implant overdenture (short term) | Very Low | Not specified |
| Edentulous adults receiving implant overdentures in one or both jaws to overcome problems with conventional complete dentures | Ball attachment system of mandibular overdentures | Telescopic attachment system of mandibular overdentures | Matrix replaced (short term) | Very Low | Not specified |
| Edentulous adults receiving implant overdentures in one or both jaws to overcome problems with conventional complete dentures | Ball attachment system of mandibular overdentures | Telescopic attachment system of mandibular overdentures | Matrix activated (short term) | Very Low | Not specified |
| Edentulous adults receiving implant overdentures in one or both jaws to overcome problems with conventional complete dentures | Ball attachment system of mandibular overdentures | Telescopic attachment system of mandibular overdentures | Patrix replaced (short term) | Very Low | Not specified |
CD008003
Current Version: CD008003.PUB3
| 1 older version
Current Evidence Gaps 1 gap
| Population | Intervention | Comparison | Outcome | Evidence Level | Downgrade Reason |
|---|---|---|---|---|---|
| Patients with root resorption | nan | nan | nan | No Evidence Yet | N/A |
Previous Versions
CD008003.PUB2
| Population | Intervention | Comparison | Outcome | Evidence Level | Studies |
|---|---|---|---|---|---|
| Patients with root resorption | nan | nan | nan | No Evidence Yet | - |
CD008050
Current Version: CD008050.PUB2
Current Evidence Gaps 13 gaps
| Population | Intervention | Comparison | Outcome | Evidence Level | Downgrade Reason |
|---|---|---|---|---|---|
| Cleft lip-cleft palate patients | rhBMP-2 with InFuse bone graft | Traditional iliac bone graft | Alveolar ridge healing | No Evidence Yet | N/A |
| Cleft lip-cleft palate patients | rhBMP-2 with InFuse bone graft | Traditional iliac bone graft | Length of hospital stay | No Evidence Yet | N/A |
| Cleft lip-cleft palate patients | rhBMP-2 with InFuse bone graft | Traditional iliac bone graft | Periapical film evaluation | No Evidence Yet | N/A |
| Cleft lip-cleft palate patients | rhBMP-2 with InFuse bone graft | Traditional iliac bone graft | CT scan evaluation | No Evidence Yet | N/A |
| Cleft lip-cleft palate patients | rhBMP-2 with InFuse bone graft | Traditional iliac bone graft | Panorex evaluation | No Evidence Yet | N/A |
| Cleft lip-cleft palate patients | rhBMP-2 with InFuse bone graft | Traditional iliac bone graft | Nasal alar base augmentation | No Evidence Yet | N/A |
| Cleft lip-cleft palate patients | rhBMP-2 with InFuse bone graft | Traditional iliac bone graft | Loss of graft | No Evidence Yet | N/A |
| Cleft lip-cleft palate patients | rhBMP-2 with InFuse bone graft | Traditional iliac bone graft | Oronasal fistula | No Evidence Yet | N/A |
| Cleft lip-cleft palate patients | rhBMP-2 with InFuse bone graft | Traditional iliac bone graft | Same day discharge | No Evidence Yet | N/A |
| Cleft lip-cleft palate patients | Traditional iliac bone graft plus fibrin glue | Traditional iliac bone graft | Dehiscence | No Evidence Yet | N/A |
| Cleft lip-cleft palate patients | Traditional iliac bone graft plus fibrin glue | Traditional iliac bone graft | Infection in wound | No Evidence Yet | N/A |
| Cleft lip-cleft palate patients | Traditional iliac bone graft plus fibrin glue | Traditional iliac bone graft | Coronal bone density | No Evidence Yet | N/A |
| Cleft lip-cleft palate patients | Traditional iliac bone graft plus fibrin glue | Traditional iliac bone graft | Coronal bone volume | No Evidence Yet | N/A |
Showing 121 to 140 of 214 review series
Summary Statistics
214
Review Series
3688
PICO Questions
Evidence Certainty
High
(%)
Moderate
(%)
Low
(%)
Very Low
(%)
No Evidence Yet
(%)
GRADE Downgrading Reasons
Risk of Bias
985
(85.8%)
Imprecision
895
(78.0%)
Inconsistency
253
(22.0%)
Indirectness
188
(16.4%)
Publication Bias
48
(4.2%)